LUMINOR THERAPEUTICS
LIVE

Serial Number

99421187

Owner

Therakos, LLC

Attorney

Adrienne Love

Filing Date

Sep 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LUMINOR THERAPEUTICS Trademark

Serial Number: 99421187

LUMINOR THERAPEUTICS is a trademark filed by Therakos, LLC on September 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Therakos, LLC (3 trademarks)

1170 US 22 East, Suite 102
Bridgewater, NJ 08807

Entity Type: 16

Trademark Details

Filing Date

September 30, 2025

Registration Date

Not Registered

Published for Opposition

March 17, 2026

Goods & Services

Pharmaceutical preparations for the treatment of immune system related diseases and disorders, autoimmue diseases, cancer, inflammation and autoinflammation diseases by use of extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy and cellular therapies

Medical and pharmaceutical consultation; medical services relating to extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies

medical device, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies

Pharmaceutical research services; Pharmaceutical products development

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 12, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 20, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 20, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 20, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 20, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 20, 2026 CNEA
ASSIGNED TO EXAMINER
Feb 19, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 30, 2025 MAFR
NEW APPLICATION ENTERED
Sep 30, 2025 NWAP